IGF1 and cancer: An aetiological role for IGF-1 and IGFBP-3 in malignancy is supported by clinical studies that associate high IGF-1 and low IGFBP-3 levels with increased risk of several cancers, such as breast, colorectum, and lung cancer [19-21].